Financing type: non-brokered private placement
Gross proceeds: $1.16-million
Offering: 23.2 million listed shares with 23.2 million warrants attached
Offering price: five cents per listed share
Warrant exercise terms: six cents per listed share for an 18-month period, subject to an acceleration
right
Commissions in securities: 192,000 finders' warrants
Commission terms: Each non-transferable warrant is exercisable into a common share at six cents for an 18-month period, subject to an acceleration right.
Disclosure: Refer to the company's news releases dated May 7, 2026, and May 26, 2026.
© 2026 Canjex Publishing Ltd. All rights reserved.